What is the recommended nebulization treatment for acute asthma exacerbations in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nebulization Treatment for Acute Asthma Exacerbations in Children

For acute asthma exacerbations in children, administer nebulized salbutamol 5 mg (or 0.15 mg/kg) via oxygen-driven nebulizer, with half doses for very young children, repeated every 15-30 minutes as needed, and add ipratropium bromide 250 mcg for severe exacerbations. 1, 2

Initial Assessment and Severity Classification

Before initiating nebulization, assess severity by looking for:

  • Moderate exacerbation: Respiratory rate >50/min, pulse >140/min, use of accessory muscles, PEF 50-70% predicted (if child can perform), too breathless to talk or feed 1, 3
  • Severe exacerbation: Poor respiratory effort, fatigue/exhaustion, agitation or reduced consciousness, PEF <50% predicted 1, 3
  • Life-threatening: PEF <33% predicted, silent chest, cyanosis, poor respiratory effort 1

Primary Bronchodilator Therapy

Salbutamol Dosing

  • Standard dose: 5 mg nebulized OR 0.15 mg/kg 1, 2
  • Very young children: Use half doses 2
  • Frequency: Repeat every 15-30 minutes if not improving 2
  • Driving gas: Use oxygen at 6-8 L/min flow rate whenever possible, as children with acute severe asthma are hypoxic 1, 3
  • Duration: 10 minutes is sufficient for bronchodilator nebulization 1

Alternative: Terbutaline

  • Dose: 10 mg nebulized OR 0.3 mg/kg 1
  • Same frequency and delivery parameters as salbutamol 1

Adding Ipratropium Bromide

Add ipratropium bromide 250 mcg to the nebulizer for severe exacerbations or if the child is not improving after initial salbutamol. 1

  • Frequency: Every 6 hours (can be given with second and third doses of albuterol in emergency settings) 1, 4
  • Evidence: In children with severe asthma, adding ipratropium to albuterol and corticosteroids significantly reduces hospitalization rates (37.5% vs 52.6%, p=0.02) 4
  • Note: No additional benefit in bronchiolitis, so reserve for confirmed asthma exacerbations 5

Concurrent Systemic Corticosteroids

Always administer systemic corticosteroids early in moderate to severe exacerbations: 1, 2

  • Prednisolone: 2 mg/kg/day for 3 days (maximum 40 mg/day) 1, 2
  • Alternative: Hydrocortisone 100 mg IV every 6 hours 1
  • Give with the second dose of bronchodilator 4

Delivery System Selection

Nebulizer vs MDI with Spacer

  • Nebulizers are preferable when: Large doses needed, coordinated breathing difficult, child acutely ill 1
  • MDI with spacer alternative: 100 mcg salbutamol, one actuation then inhale, repeat up to 20 times (may be as effective and cheaper, but not yet widely used in acute settings) 1

Equipment Specifications

  • Mouthpiece preferred over mask (except in babies/young children who won't tolerate) to maximize drug delivery 1
  • Masks with straps better for acutely ill patients when holding nebulizer is tiring 1
  • Gas flow rate: 6-8 L/min to nebulize 50% of particles to 2-5 µm diameter 1
  • Volume: 2.0-4.5 mL in nebulizer chamber; bronchodilators can be mixed together 1

Escalation for Non-Responders

If inadequate response after 3 doses of bronchodilators with corticosteroids:

  1. Aminophylline infusion: 1

    • Loading dose: 5 mg/kg IV over 20 minutes (omit if already on theophylline)
    • Maintenance: 1 mg/kg/hour
  2. Consider high-dose continuous nebulization: 6

    • Doses up to 3.7 mg/kg/hr have been used safely in PICU settings
    • Associated with low mechanical ventilation rates and short PICU stays
    • Monitor for tachycardia, hypotension, and hypokalemia
  3. Transfer to intensive care for continuous bronchodilator therapy ± mechanical ventilation 1

Monitoring During Treatment

  • Oxygen saturation: Maintain >92% in children 3
  • Clinical response: Decrease in respiratory rate, accessory muscle use, improved air entry 1
  • Heart rate: Expect mild increases (6-11 bpm increase is typical) 5
  • Decrease frequency of bronchodilators as symptoms improve 1

Common Pitfalls to Avoid

  • Do not use water for nebulization—it causes bronchoconstriction; use normal saline 1
  • Do not routinely use oxygen as driving gas in COPD patients (not applicable to children with asthma) 1
  • Do not delay corticosteroids—give early with second bronchodilator dose 4
  • Do not use ipratropium in bronchiolitis—no proven benefit 5
  • Avoid ultrasonic nebulizers—jet nebulizers produce superior bronchodilation in acute asthma 7

Emerging Evidence

Recent research suggests nebulizing albuterol with 3% hypertonic saline (rather than normal saline) produces significantly greater bronchodilator response in children with mild-moderate obstruction (41.2% vs 17.3% FEV1 improvement, p<0.0001), though this is not yet standard practice 8

Discharge Planning

24-48 hours before discharge, transition to appropriate delivery system (MDI with spacer or dry powder inhaler) based on child's age, understanding, and technique, with proper education 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Salbutamol Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ideal Oxygen Flow Rate for Asthma Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Effect of high-dose continuous albuterol nebulization on clinical variables in children with status asthmaticus.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.